moNATor
Commercial- Indications
- Multiple sclerosis
Company intelligence / Profile preview
Abreos has developed a portfolio of laboratory and point-of-care tests using its Veritope platform to monitor blood concentrations of over a dozen marketed biologic drugs. These enable personalized dosing to improve outcomes and reduce costs. The company also has a preclinical-stage program targeting Activin A for cancer-associated cachexia with promising animal model results so far.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abreos Biosciences.